Stock Earnings

Question 1

Nurix Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Nurix Therapeutics Incの総資産は$669で、純lossは$-193です。

Question 2

NRIXの主要な財務比率は何ですか？

Accepted Answer

Nurix Therapeutics Incの流動比率は4.71、純利益率は-357.4、1株当たり売上高は$0.8です。

Question 3

Nurix Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Nurix Therapeutics Inc largest revenue segment is Small Molecule and Cell Therapies, at a revenue of 54,549,000 in the most earnings release.For geography, United States is the primary market for Nurix Therapeutics Inc, at a revenue of 54,549,000.

Question 4

Nurix Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Nurix Therapeutics Incの純lossは$-193です。

Question 5

Nurix Therapeutics Incに負債はありますか？

Accepted Answer

yes、Nurix Therapeutics Incの負債は142です。

Question 6

Nurix Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Nurix Therapeutics Incの総発行済株式数は75.87株です。

Breakdown	TTM	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020
Revenue	83	54	76	38	29	17
Revenue Growth (YoY)	48%	-28.99%	100%	31%	71%	-45%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	49	45	42	38	31	16
Research & Development	301	221	189	184	116	66
Operating Expenses	350	267	232	222	147	82
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-244	-193	-143	-180	-117	-63
Income Tax Expense	0	0	--	0	0	-20
Net Income	-244	-193	-143	-180	-117	-43
Net Income Growth	39%	35%	-21%	54%	172%	105%
Shares Outstanding (Diluted)	84.15	67.12	54.33	48.61	42.9	38.86
Shares Change (YoY)	16%	24%	12%	13%	10%	241%
EPS (Diluted)	-2.9	-2.88	-2.64	-3.71	-2.73	-1.11
EPS Growth	19%	9%	-28.99%	36%	146%	-42%
Free Cash Flow	-241	-181	-89	-172	-90	-4
Free Cash Flow Per Share	-2.86	-2.69	-1.63	-3.53	-2.09	-0.1
Gross Margin	--	--	--	--	--	--
Operating Margin	-321.68%	-394.44%	-203.94%	-481.57%	-403.44%	-376.47%
Profit Margin	-293.97%	-357.4%	-188.15%	-473.68%	-403.44%	-252.94%
Free Cash Flow Margin	-290.36%	-335.18%	-117.1%	-452.63%	-310.34%	-23.52%
EBITDA	-264	-204	-148	-178	-115	-62
EBITDA Margin	-318.07%	-377.77%	-194.73%	-468.42%	-396.55%	-364.7%
D&A For EBITDA	3	9	7	5	2	2
EBIT	-267	-213	-155	-183	-117	-64
EBIT Margin	-321.68%	-394.44%	-203.94%	-481.57%	-403.44%	-376.47%
Effective Tax Rate	0%	0%	--	0%	0%	31.74%

Nurix Therapeutics Inc (NRIX) Price

NRIX Stock Price Chart

NRIX Income

Follow-Up Questions